Price · last 3 months · daily close
ABNB price
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
ValeriusBeta - Not investment advice
Research · S&P 500 · Consumer Discretionary
The numbers, the scorecard and what analysts say, with the source for each. Information, not advice.
Price · last 3 months · daily close
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
Value Scorecard · run 2026-10-18
Earnings & returns
Diluted EPS: $2.79 (2022), $7.24 (2023), $4.11 (2024), $1.03 (2025). The latest figure is half the 2022 figure or less; the framework scores that as 1.
ROE (net income / common equity): 34.0% (2022), 58.7% (2023), 31.5% (2024), 30.6% (2025). Median 32.8%, lowest 30.6%; the framework scores a median above 20% as 5.
ROIC of 29.7%: operating income of $2.54B divided by $8.56B of capital (total assets $22.21B minus current liabilities $13.65B), fiscal year to Dec 31, 2025, as filed in the 10-K (SEC EDGAR). The framework scores above 20% as 5.
Net margin of 20.4%; the framework scores above 20% as 5; gross margin 82.9%, operating margin 21.0%.
Balance sheet & cash
Net cash: total debt $2.50B, total cash $12.07B. The framework scores a net cash position as 5.
Free cash flow (operating cash flow minus capital expenditure): $3.43B (2022), $3.88B (2023), $4.52B (2024), $4.65B (2025). It rose every year; the framework scores that as 5.
Retained earnings, as filed in the 10-Ks (SEC EDGAR): -$5.96B (2022), -$3.42B (2023), -$4.22B (2024), -$5.50B (2025). The latest balance is negative (an accumulated deficit); the framework scores that as 1.
Valuation models
IV = EPS x (8.5 + 2g) x (4.4 / Y) = $4.39 x (8.5 + 2 x 0.0) x (4.4 / 4.5) = $36.49 (EPS CAGR -62.3% floored at 0%; the formula returns a negative value below -4.25% growth). Current price $173.70; price is 376.1% above the model value.
FCF/share = $7.644, stage 1 growth = 11.1% for 5 years, terminal growth = 3%, discount rate = 10%. Stage 1 PV = $39.38, PV of terminal value = $118.21, DCF value = $157.59. Current price $173.70; price is 10.2% above the model value.
Graham value $36.49 (price is 376.1% above the model value); DCF value $157.59 (price is 10.2% above the model value).
P/B of 13.14; the framework scores above 5.0 as 1.
Business quality
A moat (a brand, a network, switching costs, patents, scale, a licence) is not a number in the filings, so Valerius doesn’t score it. Below are the figures and the words moat analysis starts from, from the company’s own 10-K filings. The conclusion is yours.
Return on capital, each year
Above 15% in 3 of 6 years (2020-2025); lowest -67.1%, highest 29.7%.
Gross margin, each year
Between 74.1% and 83.1% over 7 years (a range of 9.0 points).
Competition, in the company’s own words · 10-K filed Feb 12, 2026
The latest 10-K has no section headed “Competition” that could be quoted. Open the filing to read how the company describes its markets.
Return on capital = operating income / (total assets − current liabilities), the ROIC row’s definition; 15% is the framework’s return threshold. Gross margin = gross profit / revenue. Both from each year’s 10-K via SEC EDGAR. Moat analysis commonly looks at whether returns and margins held up over many years. These figures don’t say whether the company has an advantage, what it is, or whether it will last.
Capital allocation, 2022-2025: dividends or buybacks paid in every year (pass); $10.97B paid out against $16.48B of free cash flow (pass); total debt $2.34B to $2.07B, down 11.7%, 0.8x EBITDA (pass: not up more than 10%); shares outstanding 0.63B to 0.60B, down 4.6% (pass). 4 of 4 tests passed; the framework scores that as 5.
Filings
Three kinds of event the company reported to the SEC in the last 5 years, from its filings on SEC EDGAR.
Loading...
These are events the company reported to the SEC. An auditor change or a late filing can have many causes; each date links to the filing, where the company explains it. Valerius does not score these.
Graham Formula:
IV = EPS x (8.5 + 2g) x (4.4 / Y)
EPS = $4.39, g = 0.0%, Y = 4.5
g floored at 0.0% (3-year EPS CAGR was -62.3%; below -4.25% the formula returns a negative value)
IV = $36.49
Current price $173.70 vs Graham value $36.49 — price is 376.1% above the model value.
DCF:
FCF/share = $7.644
Stage 1 growth = 11.1% for 5 years | terminal growth = 3.0% | discount rate = 10.0%
Y1: $8.492 → PV $7.720
Y2: $9.435 → PV $7.798
Y3: $10.482 → PV $7.876
Y4: $11.646 → PV $7.954
Y5: $12.939 → PV $8.034
Stage 1 PV sum = $39.38
Terminal value at end of Y5 = $190.38
PV of terminal value = $118.21
DCF value = $157.59
Current price $173.70 vs DCF value $157.59 — price is 10.2% above the model value.Data from yfinance summary figures and financial statements, and from the company’s 10-K filings via SEC EDGAR; computed at a price of $173.70. Every score is calculated from the figures by the framework’s fixed rules, and the explanation beside it is generated from the same figures: Graham value, DCF value, margin of safety, ROIC, profit margins, debt-to-equity, price-to-book, EPS trend, ROE trend, free cash flow, retained earnings and capital allocation. No AI is involved in this scorecard. The moat is shown as evidence, without a score. Read each score with the figures beside it. Intrinsic value calculations are model outputs based on stated assumptions, not predictions.
Recent headlines · third-party publishers · not investment advice
The 8 newest headlines whose title names the company, shown automatically and never chosen by Valerius. From third-party publishers via Yahoo Finance, linked to the source. Valerius doesn't write or endorse them. Not investment advice.